VA
NARI

Vident Advisory’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Vident Advisory’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,428
Closed -$223K – 1450
2023
Q4 		$223K Sell
3,428
-1,192
-26% -$71.8K 0.01% 1165
2023
Q3 		$302K Buy
+4,620
New +$291K 0.01% 899

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vident Advisory's NARI Position: Q1 2024 in Review

Vident Advisory sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2024, closing a stake of 3,428 shares — an estimated $223K sold.

Vident Advisory first reported a position in NARI in Q3 2023 and held it in 2 quarters. The position peaked at $302K in Q3 2023. 231 funds tracked by Wall St. Rank hold NARI as of Q1 2024.

  • Vident Advisory reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Vident Advisory sold 3,428 Inari Medical, Inc. Common Stock shares in Q1 2024, an estimated $223K.
  • Vident Advisory first reported a position in Inari Medical, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Vident Advisory's Inari Medical, Inc. Common Stock position peaked at $302K in Q3 2023.
  • 231 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2024.

Based on Vident Advisory's 13F filing for Q1 2024, filed 14 May 2024.